Oct 07, 2026 by Nathan Gray, CRTonline.org
Clinicians should confirm that resistant hypertension is genuine before escalating treatment, and reserve newer drugs and renal denervation for carefully selected patients who remain uncontrolled on optimized therapy or cannot tolerate more medication, according to a new expert consensus decision pathway from the American College of Cardiology (ACC).